Overexpression of PAX3 or PAX7 in mouse myoblasts (but not overexpression of other paired class homeotic transcription factors) has been shown to reduce DUX4 toxicity by competing for DNA binding sites and has been proposed as a possible mechanism of FSHD pathology [14]. The gene discussed is DUX4; the disease is facioscapulohumeral muscular dystrophy.